tyramine has been researched along with Mydriasis in 2 studies
Mydriasis: Dilation of pupils to greater than 6 mm combined with failure of the pupils to constrict when stimulated with light. This condition may occur due to injury of the pupillary fibers in the oculomotor nerve, in acute angle-closure glaucoma, and in ADIE SYNDROME.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Mydriasis induced by the postsynaptic alpha 1-agonist phenylephrine was similar in both groups of patients tested, whereas pupillary dilation caused by the release of noradrenaline tyramine was markedly greater in patients with histories of ergotamine abuse." | 7.68 | Long-term ergotamine abuse: effect on adrenergically induced mydriasis. ( Alessandri, M; Beatrice, S; Briccolani-Bandini, E; Fanciullacci, M; Pietrini, U, 1992) |
| " ABT-200 also antagonized clonidine-induced mydriasis and increased the overflow of [3H]-norepinephrine in guinea pig hippocampal slices, manifestations of blockade of alpha-2 adrenoceptors in the central nervous system." | 3.69 | Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic recepto ( Brune, ME; Buckner, SA; Giardina, WJ; Hancock, AA; Kerkman, DJ; Lee, JY; Morse, PA; Oheim, KW; Stanisic, DS; Warner, RB, 1995) |
| " Mydriasis induced by the postsynaptic alpha 1-agonist phenylephrine was similar in both groups of patients tested, whereas pupillary dilation caused by the release of noradrenaline tyramine was markedly greater in patients with histories of ergotamine abuse." | 3.68 | Long-term ergotamine abuse: effect on adrenergically induced mydriasis. ( Alessandri, M; Beatrice, S; Briccolani-Bandini, E; Fanciullacci, M; Pietrini, U, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hancock, AA | 1 |
| Buckner, SA | 1 |
| Giardina, WJ | 1 |
| Brune, ME | 1 |
| Lee, JY | 1 |
| Morse, PA | 1 |
| Oheim, KW | 1 |
| Stanisic, DS | 1 |
| Warner, RB | 1 |
| Kerkman, DJ | 1 |
| Fanciullacci, M | 1 |
| Alessandri, M | 1 |
| Pietrini, U | 1 |
| Briccolani-Bandini, E | 1 |
| Beatrice, S | 1 |
2 other studies available for tyramine and Mydriasis
| Article | Year |
|---|---|
Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic recepto
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agent | 1995 |
Long-term ergotamine abuse: effect on adrenergically induced mydriasis.
Topics: Adult; Ergotamine; Female; Humans; Male; Middle Aged; Migraine Disorders; Mydriasis; Ophthalmic Solu | 1992 |